Shopping Cart
Remove All
Your shopping cart is currently empty
Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets and binds to CD47. It demonstrates strong binding affinity to CD47 in both humans and monkeys and effectively inhibits the interaction between CD47 and SIRPα. Gentulizumab exhibits potent antitumor activity. For isotype control, refer to HumanIgG4(S228P) kappa, Isotype Control.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Gentulizumab (Gensci-059) is a humanized IgG4 antibody that targets and binds to CD47. It demonstrates strong binding affinity to CD47 in both humans and monkeys and effectively inhibits the interaction between CD47 and SIRPα. Gentulizumab exhibits potent antitumor activity. For isotype control, refer to HumanIgG4(S228P) kappa, Isotype Control. |
| Synonyms | Gentulizumab, Gensci-059 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.